messaggio

clik on the image and visit the new site

New site clik on the image

New site clik on the image

"In silico"


 From Wikipedia
If the target host* of a phage therapy treatment is not an animal the term "biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".

In silico
From:"Genomics,Proteomics and Clinical Bacteriology",N.Woodford and Alan P.Johnson

Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.


Phage Therapy is influenced by:

Phage therapy is influenced by:

Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Temporariness
 Mutation rate
Phenotypical delay
Phage cocktail

My point of view

Saturday, 9 October 2010

All phiMmar, all phiMU and D29 mycobacterium phage

Why?

MU prophages



Identity Matrix

phiMmar01/10




By Mauve:


phiMar01/06



phiMar01/07


phiMar01/08


phiMar01/09



phiMar01/10



Identity Matrix:

 phiMar01/10-phiMU01-02


phiMar01/10-phiMU01-02/D29 mycobacterium phage


By Mauve:

phiMar01/10-phiMU01-02/D29 mycobacterium phage

Posted by Rodolfo Berretti at 20:46
Labels: ,